Internal bleeding detection device developer Saranas said today it has raised $4 million in a Series B round of financing to support its Early Bird bleed detection device.
The Early bird device is designed as a standard vascular access sheath which is embedded with sensors which detect bleeding from accidentally ruptured blood vessels during cardiac procedures, including transcatheter aortic valve replacements, the Houston, Texas-based company said.
Funds from the round will support product testing and eventual FDA submission which is slated for some time this year, Saranas said.
“The Early Bird system is potentially an important medical advancement for patients who can be affected by serious bleeding complications during cardiac catheterization procedures. This new investor infusion is a strong vote of confidence in the progress of our technology. With this funding, we expect to complete product development, seek regulatory clearance in the United States and Europe and initiate a clinical pilot with physicians. I am honored and excited to work with our talented team to bring this compelling solution to market,” prez & CEO Zaffer Syed said in a press release.
